[POSSIBILITIES AND LIMITATIONS OF PREVENTION AND THERAPY OF THE DUMPING SYNDROME IN GASTRECTOMIZED PATIENTS].
D035843:Biomedical Research; D002317:Cardiovascular Agents; D003533:Cyproheptadine; D004377:Dumping Syndrome; D004876:Ergot Alkaloids; D005743:Gastrectomy; D008660:Metabolism; D008784:Methysergide; D010600:Pharmacology; D010991:Plethysmography; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors
D002317:Cardiovascular Agents; D003533:Cyproheptadine; D004876:Ergot Alkaloids; D008784:Methysergide; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors
CYPROHEPTADINE; DUMPING SYNDROME; ERGOT ALKALOIDS; GASTRECTOMY; METABOLISM; METHYSERGIDE; PHARMACOLOGY; PLETHYSMOGRAPHY; SEROTONIN; SEROTONIN INHIBITORS
POSSIBILI'A E LIMITI IN TEMA DI PREVENZIONE E TRATTAMENTO DELLA DUMPING SINDROME DEL GASTRO-RESECATO.